Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank63
5Y CAGR-31.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-31.3%/yr
Long-term compound
Percentile
P63
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202516.61%
2024-22.66%
20231.48%
2022-36.91%
2021-24.87%
2020108.26%
2019205.44%
2018546.13%
20170.00%